Literature DB >> 22555315

Chromatin accessibility at the HIV LTR promoter sets a threshold for NF-κB mediated viral gene expression.

Kathryn Miller-Jensen1, Siddharth S Dey, Nhung Pham, Jonathan E Foley, Adam P Arkin, David V Schaffer.   

Abstract

Higher order chromatin structure in eukaryotes can lead to differential gene expression in response to the same transcription factor; however, how transcription factor inputs integrate with quantitative features of the chromatin environment to regulate gene expression is not clear. In vitro models of HIV gene regulation, in which repressive mechanisms acting locally at an integration site keep proviruses transcriptionally silent until appropriately stimulated, provide a powerful system to study gene expression regulation in different chromatin environments. Here we quantified HIV expression as a function of activating transcription factor nuclear factor-κB RelA/p65 (RelA) levels and chromatin features at a panel of viral integration sites. Variable RelA overexpression demonstrated that the viral genomic location sets a threshold RelA level necessary to induce gene expression. However, once the induction threshold is reached, gene expression increases similarly for all integration sites. Furthermore, we found that higher induction thresholds are associated with repressive histone marks and a decreased sensitivity to nuclease digestion at the LTR promoter. Increasing chromatin accessibility via inhibition of histone deacetylation or DNA methylation lowered the induction threshold, demonstrating that chromatin accessibility sets the level of RelA required to activate gene expression. Finally, a functional relationship between gene expression, RelA level, and chromatin accessibility accurately predicted synergistic HIV activation in response to combinatorial pharmacological perturbations. Different genomic environments thus set a threshold for transcription factor activation of a key viral promoter, which may point toward biological principles that underlie selective gene expression and inform strategies for combinatorial therapies to combat latent HIV.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22555315      PMCID: PMC3362694          DOI: 10.1039/c2ib20009k

Source DB:  PubMed          Journal:  Integr Biol (Camb)        ISSN: 1757-9694            Impact factor:   2.192


  42 in total

Review 1.  Epigenetic modifications and human disease.

Authors:  Anna Portela; Manel Esteller
Journal:  Nat Biotechnol       Date:  2010-10       Impact factor: 54.908

Review 2.  Control of NF-kappaB-dependent transcriptional responses by chromatin organization.

Authors:  Gioacchino Natoli
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-10       Impact factor: 10.005

Review 3.  Varying virulence: epigenetic control of expression noise and disease processes.

Authors:  Kathryn Miller-Jensen; Siddharth S Dey; David V Schaffer; Adam P Arkin
Journal:  Trends Biotechnol       Date:  2011-06-21       Impact factor: 19.536

Review 4.  Epigenetic regulation of HIV latency.

Authors:  Shweta Hakre; Leonard Chavez; Kotaro Shirakawa; Eric Verdin
Journal:  Curr Opin HIV AIDS       Date:  2011-01       Impact factor: 4.283

Review 5.  Genome-wide transcription factor binding: beyond direct target regulation.

Authors:  Kyle L MacQuarrie; Abraham P Fong; Randall H Morse; Stephen J Tapscott
Journal:  Trends Genet       Date:  2011-02-04       Impact factor: 11.639

6.  Expression of alpha- and beta-globin genes occurs within different nuclear domains in haemopoietic cells.

Authors:  K E Brown; S Amoils; J M Horn; V J Buckle; D R Higgs; M Merkenschlager; A G Fisher
Journal:  Nat Cell Biol       Date:  2001-06       Impact factor: 28.824

Review 7.  Selective transcription in response to an inflammatory stimulus.

Authors:  Stephen T Smale
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 8.  NF-κB/Rel: agonist and antagonist roles in HIV-1 latency.

Authors:  Jonathan K L Chan; Warner C Greene
Journal:  Curr Opin HIV AIDS       Date:  2011-01       Impact factor: 4.283

9.  HIV promoter integration site primarily modulates transcriptional burst size rather than frequency.

Authors:  Ron Skupsky; John C Burnett; Jonathan E Foley; David V Schaffer; Adam P Arkin
Journal:  PLoS Comput Biol       Date:  2010-09-30       Impact factor: 4.475

10.  Chromatin accessibility pre-determines glucocorticoid receptor binding patterns.

Authors:  Sam John; Peter J Sabo; Robert E Thurman; Myong-Hee Sung; Simon C Biddie; Thomas A Johnson; Gordon L Hager; John A Stamatoyannopoulos
Journal:  Nat Genet       Date:  2011-01-23       Impact factor: 38.330

View more
  16 in total

1.  CRISPR-mediated Activation of Latent HIV-1 Expression.

Authors:  Prajit Limsirichai; Thomas Gaj; David V Schaffer
Journal:  Mol Ther       Date:  2015-11-26       Impact factor: 11.454

2.  A Stronger Transcription Regulatory Circuit of HIV-1C Drives the Rapid Establishment of Latency with Implications for the Direct Involvement of Tat.

Authors:  Sutanuka Chakraborty; Manisha Kabi; Udaykumar Ranga
Journal:  J Virol       Date:  2020-09-15       Impact factor: 5.103

3.  Transient Thresholding: A Mechanism Enabling Noncooperative Transcriptional Circuitry to Form a Switch.

Authors:  Katherine H Aull; Elizabeth J Tanner; Matthew Thomson; Leor S Weinberger
Journal:  Biophys J       Date:  2017-06-06       Impact factor: 4.033

Review 4.  Understanding HIV latency: the road to an HIV cure.

Authors:  Matthew S Dahabieh; Emilie Battivelli; Eric Verdin
Journal:  Annu Rev Med       Date:  2015       Impact factor: 13.739

5.  A passive-flow microfluidic device for imaging latent HIV activation dynamics in single T cells.

Authors:  Ramesh Ramji; Victor C Wong; Arvind K Chavali; Larisa M Gearhart; Kathryn Miller-Jensen
Journal:  Integr Biol (Camb)       Date:  2015-07-03       Impact factor: 2.192

6.  Quantitative evaluation and optimization of co-drugging to improve anti-HIV latency therapy.

Authors:  Victor C Wong; Linda E Fong; Nicholas M Adams; Qiong Xue; Siddharth S Dey; Kathryn Miller-Jensen
Journal:  Cell Mol Bioeng       Date:  2014-09-01       Impact factor: 2.321

7.  Viral latency and potential eradication of HIV-1.

Authors:  Kenneth A Matreyek; Ilker Oztop; Eric O Freed; Alan Engelman
Journal:  Expert Rev Anti Infect Ther       Date:  2012-08       Impact factor: 5.091

8.  Fold-Change Detection of NF-κB at Target Genes with Different Transcript Outputs.

Authors:  Victor C Wong; Shibin Mathew; Ramesh Ramji; Suzanne Gaudet; Kathryn Miller-Jensen
Journal:  Biophys J       Date:  2019-01-12       Impact factor: 4.033

9.  NF-κB-Chromatin Interactions Drive Diverse Phenotypes by Modulating Transcriptional Noise.

Authors:  Victor C Wong; Victor L Bass; M Elise Bullock; Arvind K Chavali; Robin E C Lee; Walther Mothes; Suzanne Gaudet; Kathryn Miller-Jensen
Journal:  Cell Rep       Date:  2018-01-16       Impact factor: 9.423

10.  Orthogonal control of expression mean and variance by epigenetic features at different genomic loci.

Authors:  Siddharth S Dey; Jonathan E Foley; Prajit Limsirichai; David V Schaffer; Adam P Arkin
Journal:  Mol Syst Biol       Date:  2015-05-05       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.